Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7

1.

Role of the intracellular domain of the human type I interferon receptor 2 chain (IFNAR2c) in interferon signaling. Expression of IFNAR2c truncation mutants in U5A cells.

Russell-Harde D, Wagner TC, Rani MR, Vogel D, Colamonici O, Ransohoff RM, Majchrzak B, Fish E, Perez HD, Croze E.

J Biol Chem. 2000 Aug 4;275(31):23981-5.

3.

The short form of the interferon alpha/beta receptor chain 2 acts as a dominant negative for type I interferon action.

Pfeffer LM, Basu L, Pfeffer SR, Yang CH, Murti A, Russell-Harde D, Croze E.

J Biol Chem. 1997 Apr 25;272(17):11002-5.

4.

The human type I interferon receptor. Identification of the interferon beta-specific receptor-associated phosphoprotein.

Croze E, Russell-Harde D, Wagner TC, Pu H, Pfeffer LM, Perez HD.

J Biol Chem. 1996 Dec 27;271(52):33165-8.

5.

Expression and signaling specificity of the IFNAR chain of the type I interferon receptor complex.

Constantinescu SN, Croze E, Murti A, Wang C, Basu L, Hollander D, Russell-Harde D, Betts M, Garcia-Martinez V, Mullersman JE, Pfeffer LM.

Proc Natl Acad Sci U S A. 1995 Nov 7;92(23):10487-91.

6.

Reconstitution of a high affinity binding site for type I interferons.

Russell-Harde D, Pu H, Betts M, Harkins RN, Perez HD, Croze E.

J Biol Chem. 1995 Nov 3;270(44):26033-6.

7.

The use of Zwittergent 3-14 in the purification of recombinant human interferon-beta Ser17 (Betaseron).

Russell-Harde D, Knauf M, Croze E.

J Interferon Cytokine Res. 1995 Jan;15(1):31-7.

PMID:
7648432

Supplemental Content

Loading ...
Support Center